Detection and characterization of mechanisms of action of aneugenic chemicals.
A comprehensive evaluation of the genotoxic potential of chemicals requires the assessment of the ability to induce gene mutations and structural chromosome (clastogenic activity) and numerical chromosome (aneugenic activity) aberrations. Aneuploidy is a major cause of human reproductive failure and an important contributor to cancer and it is therefore important that any increase in its frequency due to chemical exposures should be recognized and controlled. The in vitro binucleate cell micronucleus assay provides a powerful tool to determine the ability of a chemical to induce chromosome damage. The application of an anti-kinetochore antibody to micronuclei allows their classification into kinetochore-positive and kinetochore-negative, indicating their origin by aneugenic or clastogenic mechanisms, respectively. The availability of chromosome-specific centromere probes allows the analysis of the segregation of chromosomes into the daughter nuclei of binucleate cells to evaluate chromosome non-disjunction. Quantitative relationships between the two major causes of aneuploidy, chromosome loss and non-disjunction, can be determined. The mechanisms leading to chromosome loss and non-disjunction can be investigated by the analysis of morphological and structural changes in the cell division apparatus by the application of specific stains and antibodies for various cell division components. We illustrate such analyses by the demonstration of the interaction of the monomer bisphenol-A with the centrosome of the mitotic spindle and the folic acid antagonist pyrimethamine with the centromeres of chromosomes. Both types of modifications lead to the induction of aneuploidy in exposed cells. Our studies also implicate the products of the p53 and XPD genes in the regulation of the fidelity of chromosome segregation at mitosis.
Parry
E M
EM
Centre for Molecular Genetics and Toxicology, School of Biological Sciences, University of Wales Swansea, Singleton Park, Swansea SA2 8PP, UK. E.M.Parry@swansea.ac.uk
Parry
J M
JM
Corso
C
C
Doherty
A
A
Haddad
F
F
Hermine
T F
TF
Johnson
G
G
Kayani
M
M
Quick
E
E
Warr
T
T
Williamson
J
J
D000782:Aneuploidy; D000818:Animals; D001559:Benzhydryl Compounds; D002460:Cell Line; D004265:DNA Helicases; D004268:DNA-Binding Proteins; D005493:Folic Acid Antagonists / Q000633:toxicity; D016158:Genes, p53; D006801:Humans; D066298:In Vitro Techniques; D007621:Karyotyping; D015162:Micronucleus Tests / Q000379:methods; D008938:Mitosis / Q000235:genetics; D009152:Mutagenicity Tests / Q000379:methods*; D009153:Mutagens / Q000633:toxicity*; D010636:Phenols / Q000633:toxicity; D011506:Proteins / Q000235:genetics; D011739:Pyrimethamine / Q000633:toxicity; D014157:Transcription Factors; D051759:Xeroderma Pigmentosum Group D Protein; D000098826:Bisphenol A Compounds
D001559:Benzhydryl Compounds; D004265:DNA Helicases; D004268:DNA-Binding Proteins; D005493:Folic Acid Antagonists; D009153:Mutagens; D010636:Phenols; D011506:Proteins; D011739:Pyrimethamine; D014157:Transcription Factors; D051759:Xeroderma Pigmentosum Group D Protein; C497292:ERCC2 protein, human; C006780:bisphenol A; D000098826:Bisphenol A Compounds